Short Interest in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Increases By 100.0%

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) saw a significant increase in short interest in December. As of December 15th, there was short interest totalling 400 shares, an increase of 100.0% from the November 30th total of 200 shares. Based on an average trading volume of 2,900 shares, the days-to-cover ratio is currently 0.1 days.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

An institutional investor recently bought a new position in First Trust Nasdaq Pharmaceuticals ETF stock. International Assets Investment Management LLC acquired a new position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 2,662 shares of the company’s stock, valued at approximately $73,000. International Assets Investment Management LLC owned about 0.41% of First Trust Nasdaq Pharmaceuticals ETF at the end of the most recent quarter.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

FTXH stock traded down $0.15 during midday trading on Friday, hitting $27.24. 1,314 shares of the stock traded hands, compared to its average volume of 4,948. The stock’s fifty day simple moving average is $27.95 and its 200-day simple moving average is $28.25. The firm has a market cap of $16.34 million, a P/E ratio of 15.98 and a beta of 0.70. First Trust Nasdaq Pharmaceuticals ETF has a 1-year low of $25.73 and a 1-year high of $29.72.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The firm also recently declared a dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Friday, December 13th will be given a dividend of $0.1304 per share. The ex-dividend date of this dividend is Friday, December 13th. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.